D
BioLife Solutions, Inc. BLFS
$22.44 -$1.34-5.64%
Recommendation
Sell
Prev Close
$23.78
Volume
591,144
Avg Vol (90D)
340,584
Market Cap
$1.12B
Dividend & Yield
--
52-Week Range
$14.84 - $29.55
P/E (TTM)
--
EPS (TTM)
-$0.4556
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Commit To Buy Biolife Solutions At $20, Earn 34.4% Annualized Using Options
4/3/2025 - Stock Options Channel
With BioLife Solutions, Inc. (NASDAQ:BLFS) It Looks Like You'll Get What You Pay For
4/3/2025 - Simply Wall St
BioLife Solutions (NASDAQ:BLFS) Lowered to Sell Rating by StockNews.com
4/2/2025 - MarketBeat
BioLife Solutions (NASDAQ:BLFS) Trading Down 7.7% - Here's Why
4/1/2025 - MarketBeat
BioLife Solutions (BLFS, $22.84) entered Downtrend as Momentum indicator drops below 0 level on Mar 31, 2025
4/1/2025 - Tickeron - Technical Analysis
BioLife Solutions (BLFS, $22.84) Stochastic Oscillator left the overbought zone on March 31, 2025
4/1/2025 - Tickeron - Technical Analysis
BioLife Solutions (BLFS, $22.84) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 31, 2025
4/1/2025 - Tickeron - Technical Analysis
Noteworthy Monday Option Activity: BX, BLFS, ALT
3/31/2025 - Stock Options Channel
Notable Two Hundred Day Moving Average Cross - BLFS
3/31/2025 - Market News Video
BioLife Solutions (BLFS, $25.96) Stochastic Oscillator left the overbought zone on March 28, 2025
3/29/2025 - Tickeron - Stocks
BioLife Solutions (BLFS, $25.82) entered Downtrend as Momentum indicator drops below 0 level on Mar 25, 2025
3/26/2025 - Tickeron - Technical Analysis
BioLife Solutions Inc (BLFS) Trading Down 2.8% on Mar 25
3/25/2025 - GuruFocus
BioLife Solutions (BLFS, $26.41) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 24, 2025
3/25/2025 - Tickeron - Stocks
5 Low-Leverage Stocks to Buy Amid Trump's Tariff Woes
3/24/2025 - Zacks Investment Research
Proficio Capital Partners LLC Takes $638,000 Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
3/24/2025 - MarketBeat
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Acquired by Charles Schwab Investment Management Inc.
3/23/2025 - MarketBeat
BioLife Solutions Inc (BLFS) Shares Gap Down to $24.99 on Mar 22
3/22/2025 - GuruFocus
BioLife Solutions (BLFS, $24.99) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 21, 2025
3/22/2025 - Tickeron - Stocks
BioLife Solutions Inc (BLFS) Appoints Cathy Coste as Director and Audit Committee Chair
3/21/2025 - GuruFocus
BioLife Solutions (NASDAQ:BLFS) Stock Rating Upgraded by StockNews.com
3/21/2025 - MarketBeat
BioLife Solutions Inc (BLFS) Shares Gap Down to $25.06 on Mar 21
3/21/2025 - GuruFocus
BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sarah Aebersold Sells 2,695 Shares
3/20/2025 - MarketBeat
BioLife Solutions (BLFS, $25.48) entered Downtrend as Momentum indicator drops below 0 level on Mar 19, 2025
3/20/2025 - Tickeron - Stocks
Sarah Aebersold Sells 2,695 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) Stock
3/19/2025 - MarketBeat
Sarah Aebersold Sells 5,632 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) Stock
3/19/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$82.25M
EBITDA (TTM)
$1.20M
EBIT (TTM)
-$7.13M
Net Income (TTM)
-$20.18M
Balance Sheet
Total Assets (Q)
$399.49M
Total Debt (Q)
$30.17M
Total Liabilities (Q)
$50.58M
Book Value Per Share (Q)
$7.44
Cash Flow
Cash from Operations (TTM)
$8.43M
Cash from Investing (TTM)
$58.30M
Cash from Financing (TTM)
-$6.78M
Net Change in Cash (TTM)
$59.95M
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
2.43
7-Day Total Return
-13.09%
30-Day Total Return
-18.43%
60-Day Total Return
-17.68%
90-Day Total Return
-10.28%
Year to Date Total Return
-14.29%
1-Year Total Return
29.56%
2-Year Total Return
11.48%
3-Year Total Return
-7.27%
5-Year Total Return
128.05%
52-week Low
Apr 18, 2024 - $14.84
52-week High
Jan 30, 2025 - $29.55
Valuation
Market Cap
$1.12B - Small Cap
Enterprise Value
$1.04B
Price/Sales (TTM)
13.89
Price/Book (Q)
3.20
Dividends and Shares
Shares Outstanding
48.03M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biolifesolutions.com
Phone Number
425 402 1400
Address
3303 Monte Villa Parkway
Bothell, WA 98021
Country
United States
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings